- Home
- ADAG vs IAF Comparison
ADAG vs IAF Comparison
Compare ADAG & IAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADAG
- IAF
- Stock Information
- Founded
- ADAG 2011
- IAF 1985
- Country
- ADAG China
- IAF United States
- Employees
- ADAG N/A
- IAF N/A
- Industry
- ADAG Biotechnology: Pharmaceutical Preparations
- IAF Finance/Investors Services
- Sector
- ADAG Health Care
- IAF Finance
- Exchange
- ADAG Nasdaq
- IAF Nasdaq
- Market Cap
- ADAG 110.8M
- IAF 127.6M
- IPO Year
- ADAG 2021
- IAF N/A
- Fundamental
- Price
- ADAG $2.24
- IAF $4.61
- Analyst Decision
- ADAG Strong Buy
- IAF
- Analyst Count
- ADAG 2
- IAF 0
- Target Price
- ADAG $7.00
- IAF N/A
- AVG Volume (30 Days)
- ADAG 140.2K
- IAF 90.4K
- Earning Date
- ADAG 08-12-2025
- IAF 01-01-0001
- Dividend Yield
- ADAG N/A
- IAF 11.44%
- EPS Growth
- ADAG N/A
- IAF N/A
- EPS
- ADAG N/A
- IAF N/A
- Revenue
- ADAG $103,204.00
- IAF N/A
- Revenue This Year
- ADAG $9,789.15
- IAF N/A
- Revenue Next Year
- ADAG $29.92
- IAF N/A
- P/E Ratio
- ADAG N/A
- IAF N/A
- Revenue Growth
- ADAG N/A
- IAF N/A
- 52 Week Low
- ADAG $1.33
- IAF $3.60
- 52 Week High
- ADAG $3.58
- IAF $4.59
- Technical
- Relative Strength Index (RSI)
- ADAG 52.00
- IAF 53.54
- Support Level
- ADAG $2.24
- IAF $4.53
- Resistance Level
- ADAG $2.49
- IAF $4.63
- Average True Range (ATR)
- ADAG 0.22
- IAF 0.06
- MACD
- ADAG 0.00
- IAF -0.00
- Stochastic Oscillator
- ADAG 14.81
- IAF 86.21
About ADAG Adagene Inc.
Adagene Inc is a platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development, and production of monoclonal antibody drugs for cancers. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity, as highlighted by the company's immunotherapy pipeline.
About IAF abrdn Australia Equity Fund Inc.
Aberdeen Australia Equity Fund Inc is a non-diversified closed-end investment management company. With a core focus on long-term capital appreciation, it invests predominantly in equity securities listed on the Australian Stock Exchange. Its secondary objective is current income, which it expects to derive from dividends and interest on Australian corporate and governmental securities. Its investment portfolio comprises diversified sectors that include Financials, Health Care, Materials, Information Technology, Real Estate, and other sectors.